Sigma-Aldrich gets MJFF grant to develop rat PD models
US life science firm Sigma-Aldrich has received a Michael J Fox Foundation (MJFF) grant to create knockout-rat models of Parkinson’s disease (PD) to improve preclinical drug development.
Archives for October 5, 2009
Reliance on external partners threatens innovation; experts
Pharma’s reliance on outsourcing and products developed by biotechs could cause the pace of innovation to “decline considerably”, according to experts that are concerned about the lack of funding for small businesses.
Hospira buys facility & filgrastim rights to boost biogenerics
Hospira has acquired the worldwide rights to filgrastim and a Croatian biologics plant from Pliva, increasing its presence in the biogenerics field, and told in-PharmaTechnologist that further expansions are possible.
GSK’s H1N1 orders total 440m doses
GSK has won 22 government orders for its H1N1 swine flu vaccine in the past two months, taking total sales to 440m doses which media reports suggest will earn the company £2.2bn ($3.5bn).
Appointments at Omnicare, Kendle and Clinsys – People on the move
Outsourcing-Pharma presents its latest round up movements in the pharma outsourcing sector, including appointments at Omnicare, Kendle and Clinsys.
French govt unlikey to relinquish grip on health spending, says BMI
Despite the government’s “aggressive” promotion of generic drugs, pharmaceutical spending in France will continue to grow, according to new analysis by Business Monitor International (BMI).